Literature DB >> 11798143

Morphological aspects of peritoneal sclerosis.

G Garosi1, N Di Paolo.   

Abstract

The term peritoneal sclerosis simply means the presence of sclerotic tissue in the peritoneum. Qualitative and quantitative morphological aspects indicate that there are two nosological entities: simple sclerosis and sclerosing peritonitis. Simple sclerosis is a thin (<40-50 microm) layer of submesothelial sclerotic tissue often limited to certain peritoneal areas, with monotonous histology. It is a component of the slight anatomical alterations constantly detectable in peritoneal dialysis patients. Sclerosing peritonitis is characterized by very thick (1,0004,000 microm) sclerotic tissue involving the whole peritoneal wall, often with inflammatory infiltrates, microabscesses, giant cells of macrophagic origin, calcifications and severe vascular alterations. Intermediate stages between simple sclerosis and sclerosing peritonitis have rarely been detected. Simple sclerosis and sclerosing peritonitis also seem to be distinct with respect to frequency, etiology, reproducibility in animal models and clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11798143

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  10 in total

1.  Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.

Authors:  Anne-Catherine Raby; Chantal S Colmont; Ann Kift-Morgan; Jörg Köhl; Matthias Eberl; Donald Fraser; Nicholas Topley; Mario O Labéta
Journal:  J Am Soc Nephrol       Date:  2016-07-18       Impact factor: 10.121

2.  CD147 expression in peritoneal injury.

Authors:  Harald Seeger; Joerg Latus; Daniel Kitterer; M Dominik Alscher; Dagmar Biegger; Jin Chen; Ilka Edenhofer; Rudolf P Wüthrich; Stephan Segerer
Journal:  Clin Exp Nephrol       Date:  2017-05-27       Impact factor: 2.801

3.  Encapsulating peritoneal sclerosis in an Italian center: thirty year experience.

Authors:  Valerio Vizzardi; Massimo Sandrini; Silvia Zecchini; Sara Ravera; Luigi Manili; Giovanni Cancarini
Journal:  J Nephrol       Date:  2015-10-31       Impact factor: 3.902

Review 4.  Mesothelial cells in tissue repair and fibrosis.

Authors:  Steven E Mutsaers; Kimberly Birnie; Sally Lansley; Sarah E Herrick; Chuan-Bian Lim; Cecilia M Prêle
Journal:  Front Pharmacol       Date:  2015-06-09       Impact factor: 5.810

5.  Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients.

Authors:  Sudabeh Alatab; Iraj Najafi; Gholamreza Pourmand; Mostafa Hosseini; Soroosh Shekarchian
Journal:  Ren Fail       Date:  2016-10-24       Impact factor: 2.606

6.  The association between soluble intercellular adhesion molecule-1 levels in drained dialysate and peritoneal injury in peritoneal dialysis.

Authors:  Yusuke Igarashi; Yoshiyuki Morishita; Hiromichi Yoshizawa; Reika Imai; Toshimi Imai; Ichiro Hirahara; Tetsu Akimoto; Susumu Ookawara; Kenichi Ishibashi; Shigeaki Muto; Daisuke Nagata
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606

7.  The spectrum of podoplanin expression in encapsulating peritoneal sclerosis.

Authors:  Niko Braun; M Dominik Alscher; Peter Fritz; Joerg Latus; Ilka Edenhofer; Fabian Reimold; Seth L Alper; Martin Kimmel; Dagmar Biegger; Maja Lindenmeyer; Clemens D Cohen; Rudolf P Wüthrich; Stephan Segerer
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

Review 8.  Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

Review 9.  Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis.

Authors:  Raffaele Strippoli; Roberto Moreno-Vicente; Cecilia Battistelli; Carla Cicchini; Valeria Noce; Laura Amicone; Alessandra Marchetti; Miguel Angel Del Pozo; Marco Tripodi
Journal:  Stem Cells Int       Date:  2016-01-31       Impact factor: 5.443

Review 10.  Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options.

Authors:  Rajesh M Jagirdar; Andreas Bozikas; Sotirios G Zarogiannis; Maria Bartosova; Claus Peter Schmitt; Vassilios Liakopoulos
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.